Atopic Dermatitis

The AJMC^® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

Latest News

Lebrikizumab improved quality of life and mental health in patients with atopic dermatitis in a pair of studies. | Image Credit: InfiniteStudio - stock.adobe.com

Lebrikizumab Improves Quality of Life, Disease Control in Patients With Atopic Dermatitis

By Jared Kaltwasser

May 15th 2025

Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond physical symptom improvements.

FDA stamp of approval | Image Credit: Olivier Le Moal - stock.adobe.com

FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis

By Brooke McCormick

December 16th 2024

man resting hands on top of walking cane | Image Credit: sergign - stock.adobe.com

Study Finds Increased Impaired Mobility by Sex, Age in Atopic Dermatitis

By Brooke McCormick

June 30th 2024

E-cigarettes | Image Credit: lezinav - stock.adobe.com

Parental e-Cigarette Use May Increase Pediatric AD Risk

By Brooke McCormick

May 22nd 2024

Female patient with AD | Image Credit: Prostock-studio - stock.adobe.com

Study: Visible AD Impacts Romantic Relationships, Occupation, Sexual Health of French Female Patients

By Brooke McCormick

May 19th 2024

Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access

Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.

Atopic Dermatitis Payer Perspectives

More News

doctor looking at rash on patient's arm using magnifying glass

May 25th 2023

Combo Therapy Relieves Delayed Rash Symptoms in AD Following mRNA Vaccine

Hayden E. Klein

In a case report, dupilumab and prednisone were among the treatments for atopic dermatitis (AD) used to relieve a patient of her delayed generalized hypersensitivity reaction to the mRNA COVID-19 vaccine.

Mindfulness and meditation tag cloud: © elenabsl - stock.adobe.com

May 18th 2023

Mindfulness, Self-compassion Effective AD Treatment Options

Experts report that among skin diseases, atopic dermatitis has the lowest reported quality of life.

Atopic Dermatitis on the diagnosis list, medical concept: © Michail Petrov - stock.adobe.com

May 12th 2023

Atopic Dermatitis Treatment Equally Effective in Extrinsic, Intrinsic Subtypes

Patients who have extrinsic (EAD) or intrinsic atopic dermatitis (IAD) serve to benefit equally from dupilumab, even when considering immunoglobulin E levels, which are elevated in EAD but remain normal in IAD.

image of person with rash

May 6th 2023

Patient and Caregiver Considerations in Eczema Clinical Trial Participation

A recent survey assessed the factors that adult patients with eczema and caregivers find important regarding clinical trial participation decision-making.

Image of a consultation

May 3rd 2023

Research Should Focus More on Modifiable Risk Factors in Hand Eczema Disparities to Better Tailor Treatment

Study investigators stress the importance of health care professionals familiarizing themselves with risk factors among a more diverse patient population.

Knee Pain. Blue Human Anatomy Body 3D render on black background: © m3ron - stock.adobe.com

April 29th 2023

Asthma, Eczema Associated With Higher Risk for Osteoarthritis

The study findings suggest that treatments for allergic reactions could help decrease the risk of having joint problems.

April 24th 2023

Dr Raj Chovatiya on Optimizing Patient-Centered Care in Atopic Dermatitis

By better understanding the nature of atopic dermatitis and its varying comorbidities, providers might be able to better predict patient outcomes, said Raj Chovatiya, MD, PhD, assistant professor of dermatology, Northwestern University Feinberg School of Medicine.

Diagnostic Challenges Facing Patients with Atopic Dermatitis

April 24th 2023

Diagnostic Challenges Facing Patients with Atopic Dermatitis

Key opinion leaders navigate diagnostic challenges associated with atopic dermatitis.

Atopic Dermatitis Overview

April 24th 2023

Atopic Dermatitis Overview

Casey Butrus, PharmD, leads a panel of experts in a discussion surrounding atopic dermatitis.

April 18th 2023

Providers Need to Be Educated About How Conditions May Vary in Skin of Color, Says Dr Andrew Alexis

Laura Joszt, MA

Lack of knowledge about how skin conditions present on lightly pigmented skin has resulted in diagnostic delays, underassessment, and an impact on quality of life for patients with skin of color.

Mental illness word cloud: © ibreakstock - stock.adobe.com

April 14th 2023

Understanding the Impact of Eczema, Psoriasis on Risk of Severe Mental Illness

Investigators compared outcomes for severe mental illness between patients with both chronic skin conditions and healthy controls, using data from the UK Clinical Practice Research Datalink GOLD.

Screenshot of Emma Guttman-Yassky, MD, PhD, smiling

April 9th 2023

Atopic Dermatitis Treatment Is Still More Trial and Error Than Personalized: Dr Emma Guttman-Yassky

Laura Joszt, MA

While the future is bright with potential for personalized medicine to treat atopic dermatitis, current treatment is still more like trial and error, said Emma Guttman-Yassky, MD, PhD, FAAD, of the Icahn School of Medicine at Mount Sinai.

Close up of a man using mobile smart phone: © tatsianamaphoto - stock.adobe.com

April 5th 2023

WhatsApp Effective as Atopic Dermatitis Education Tool

This study investigated potential benefits of a virtual education intervention for atopic dermatitis that targeted Hispanic Americans and Spanish-speaking populations.

Screenshot of Eva Parker, MD, smiling during an interview

March 27th 2023

Dr Eva Parker Discusses the Nexus of Climate Change, Atopic Dermatitis, and Mental Health

Laura Joszt, MA

Mental health is an underrepresented issue in dermatology even though numerous skin diseases are associated with mental health diseases, said Eva R. Parker, MD, associate professor of dermatology at Vanderbilt University Medical Center and president of the Nashville Dermatologic Society.

Image of a pediatrician checking a patient: Odua Images - stock.adobe.com

March 22nd 2023

Pediatric Patients See Benefit in Short-, Long-term Treatment for AD

Data from the LIBERTY AD PRESCHOOL trial, and its ongoing open-label extension analysis show that dupilumab is safe and clinically effective, and can lead to statistically significant symptom improvement among patients aged 6 months to 17 years who have moderate to severe atopic dermatitis (AD).

Image of cancer cells: peterschreiber.media - stock.adobe.com

March 17th 2023

Patients With AD May Have Greater Risk of Certain Malignancies

Investigators of this study noted the need for more data on risks of malignancies among patients who have atopic dermatitis (AD), with the chronic skin condition already having significant associations with nonmelanoma skin cancer, lymphoma, keratinocyte carcinoma, and pancreatic and kidney cancers.

Review Supports Systemic Therapy's Efficacy for Severe Atopic Dermatitis

March 10th 2023

Review Supports Systemic Therapy's Efficacy for Severe Atopic Dermatitis

A meta-analysis and review of 9 randomized trials found high-quality evidence demonstrating the benefits of dupilumab in patients with severe atopic dermatitis.

anatomy image

March 4th 2023

Is Atopic Dermatitis Only a Skin Disease, or Is It Something More?

A group of dermatologists and dermatology students studied why atopic dermatitis may be related to certain cardiovascular diseases, neuropsychiatric diseases, autoimmune diseases, and obesity.

Image representing pediatric patients

March 1st 2023

AD Improvement Following Combo Therapy Not Affected by Comorbidities

Study results presented at this year’s American Academy of Allergy Asthma & Immunology annual meeting displayed dupilumab efficacy in children aged 6 months to 5 years who had atopic dermatitis (AD).

Map of the United States

February 22nd 2023

Eczema Prevalence Varies by Race and Ethnicity, With Overall Increase Seen

Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.

Image of an expensive price tag

February 15th 2023

Caregiver OOP Costs in AD Higher for Pediatric vs Adult Patients

This study investigated the impact atopic dermatitis (AD) has on out-of-pocket (OOP) costs for caregivers of pediatric patients with the chronic skin condition.

Image of a digital reminder

February 11th 2023

Eczema Self-management for Patients, Caregivers Benefits From Online Assistance

This exploration of eczema self-management investigated the potential effectiveness of 2 online behavioral interventions, 1 each for young patients and their parents and/or caregivers.

Image of a stethoscope next to a globe

February 8th 2023

Greater Understanding of Eczema’s Prevalence Needed to Improve Treatment, Prevention

The authors conducted a subanalysis of data on 100,000-plus children from 3 studies to estimate the global prevalence and severity of eczema; they used linear mixed models to do so.

Image of a highway

February 2nd 2023

AD Progression Adversely Influenced by Outdoor Air Pollution

With atopic dermatitis (AD) prevalence increasing around the world, primarily in developing countries, investigators evaluated the potential for pollution to have an impact on development of the chronic skin condition among an adult population.

Image of a doctor and patient talking

January 27th 2023

Guidance for AD Management Refreshed With New Recommendations

A team of experts from the United States and Canada performed this systematic review, considering for the first time patient values and preferences for their atopic dermatitis (AD) care.

Image of physician and patient of color

January 24th 2023

ACAAI Report Highlights AD, Allergy Care Disparities and Proposed Solutions

Following member surveys, expert interviews, and roundtable discussions, the American College of Allergy, Asthma, and Immunology (ACAAI) has released new recommendations for overcoming care disparities among those who have atopic dermatitis (AD) and food allergies.

Image of atopic skin irritation.

January 17th 2023

Atopic Eczema Significantly Associated With Excessive Scarring in New UK Analysis

Using data from the UK Biobank, potential correlations were investigated between excessive skin scarring outcomes arising from comorbidities among 230,000-plus European individuals.

Image of a stressed mother

January 12th 2023

Stress Management Important for Mothers of Pediatric Patients With Atopic Dermatitis

The parents of pediatric patients who have atopic dermatitis experience stress just as their children do, and this study investigated how that stress manifests among the parents, comparing outcomes between mothers and fathers.

Image of a brain

January 11th 2023

Eczema Exhibits Potential Protection Against Brain Cancer Development

For 2 important reasons—that brain cancer is so aggressive and its risk may be elevated in the presence of certain allergies—investigators of a meta-analysis set out to investigate potential connections between eczema and various brain cancers.

Image of inflamed skin

January 4th 2023

Self-care for Atopic Dermatitis Potentially Feasible as Treatment Intervention

With mixed findings from previous studies focused on atopic dermatitis and the use of cognitive behavioral therapy (CBT) as a treatment modality, investigators modified an existing online CBT intervention to account for the lack of clinical psychologists in the dermatological space.

<1 2 3 4 5 6 7 8 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions